About EffRx

EffRx Pharmaceuticals SA is an innovative specialty pharmaceutical company focused on the development of novel therapeutic entities for a variety of orphan and specialty indications. Our goal is to improve the quality of life of patients with unmet medical needs.



The product portfolio is led by already launched Binosto® for the treatment of postmenopausal osteoporosis. EffRx is currently further expanding its product pipeline. The lead development product, EX404, targets polycystic ovary syndrome (PCOS) in adolescents.


© 2015 EffRx Pharmaceuticals